Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab + Paclitaxel in Metastatic/Recurrent SCCHN
NCT01264328Phase 2Completed
- Start
- Mar 2011
- Primary completion
- Oct 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in squamous cell carcinoma of the head and neck (HNSCC). Started Mar 2011; status: completed.
02
Drugs
panitumumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01264328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01264328.